Competition Commission on Friday approved the proposed merger of Air India and Vistara subject to certain conditions. The development is a major step forward for Tata Group in consolidating its aviation business. In a post on platform X, the Competition Commission of India (CCI) on Friday said it has approved the merger. "CCI approves the merger of Tata SIA Airlines into Air India, and acquisition of certain shareholding by Singapore Airlines in Air India subject to compliance of voluntary commitments offered by the parties," it said.
Fair trade regulator CCI on Wednesday issued the draft regulations for commitment and settlement provisions under the competition law. The provisions, introduced in the Competition Act through the amendments made earlier this year, are aimed at ensuring quicker market correction, according to the Competition Commission of India (CCI). Stakeholders can submit their comments on the draft regulations from August 24 to September 13, according to communications issued by the regulator. A commitment application should be filed within 45 days from the receipt of CCI order on investigation. In the case of a settlement application, the same has to be filed within 45 days f receiving the Director General's report. For both, commitment and settlement applications, the 45-day period could be extended if CCI is satisfied that there is a sufficient cause for extension. "The settlement amount may extend up to the maximum amount of penalty that would have otherwise been leviable under section 27
In the 2020 case, TML dealer Kanchan Motors of Nashik made similar allegations that TML coerced dealers in various ways
In March 2023, the Competition Commission of India had granted approval to AGI Greenpac's takeover of HNG
Competition Commission on Thursday said it has approved Ipca Laboratories' proposed 59.38 per cent stake purchase in Unichem Laboratories. The proposed deal involves the company buying 33.38 per cent shareholding in Unichem Laboratories pursuant to a share purchase agreement. Further, Ipca Laboratories has to make an open offer to buy an additional 26 per cent stake in listed Unichem Laboratories under Sebi norms. In a release, the Competition Commission of India (CCI) said the Ipca Laboratories will acquire up to 59.38 per cent stake in the target company. The deal has been cleared by the regulator, as per the release. Deals beyond a certain threshold require the approval of CCI, which keeps a tab on unfair business practices in the marketplace.
By extending jurisdiction beyond direct participants, legal reform strengthens competition enforcement
Moves SC, alleging the tribunal ignored relevant evidence
In an earlier December filing in a lower tribunal, Google said CCI officers had "copypasted" parts of a European ruling against the U.S. firm in a similar case. CCI denied the accusation
The companies join the likes of Bharat Matrimony and Shaadi.com, which have already approached the high court challenging Google's billing policies
People in the know said that while CCI's scrutiny is unlikely to have any material impact on the business of the airlines, it could affect the timeline of the merger
Anti-trust regulator Competition Commission of India (CCI) on Tuesday said it has cleared the proposed deal involving Concentrix Corporation and Marnix Lux. Concentrix Corporation is a US-based firm engaged in providing customer experience services. The proposed combination envisages indirect acquisition of Marnix Lux SA (Marnix Lux) by Concentrix Corporation and acquisition of around 22 per cent shareholding in the combined entity by Marnix Lux shareholders, according to an official release. Marnix Lux is the parent company of Webhelp S.A.S. (Webhelp). Webhelp is active in the business process outsourcing services and specialised services segment. Deals beyond a certain threshold require approval from the regulator, which keeps a tab on unfair business practices as well as promotes fair competition in the marketplace.
The proposed combination envisages indirect acquisition of Marnix Lux SA (Marnix Lux) by Concentrix Corporation
Competition Commission of India (CCI) has issued a show cause notice to the parties with respect to the proposed merger of Tata Group airlines Vistara and Air India, according to a source. The fair trade watchdog issues notice asking why an investigation should not be initiated only after forming a prima-facie opinion that the deal could adversely impact competition in the marketplace. Vistara and Air India are the two full-service carriers that are part of the Tata Group, and Singapore Airlines holds a 49 per cent stake in Vistara. In November last year, Tata Group announced the merger of Vistara with Air India under a deal wherein Singapore Airlines will also acquire a 25.1 per cent stake in Air India. The deal would mark a major consolidation in India's fast-growing aviation space. The source on Tuesday said CCI has issued a show cause notice on the deal. Air India did not comment. The approval for the proposed combination was sought from CCI in April this year. The parties to
Apple could be asked to make changes to its commission policies and app store billing by the CCI, experts said
As the CCI chairperson, with the CCI now having a full quorum, my top priority is to address the pending cases related to antitrust and anti-profiteering
The Competition Commission of India (CCI) on Tuesday said it has cleared the proposed deal involving Manipal Health Enterprises Pvt Ltd and Manipal Education and Medical Group India Pvt Ltd (MEMG India). Manipal Health Enterprises Pvt Ltd (MHEPL) operates a chain of multi-speciality hospitals under the brand name 'Manipal Hospitals', while MEMG India is a wholly-owned subsidiary of RSP Trust India and belongs to the Pai family group. In a tweet on Tuesday, CCI said it has approved the "proposed combination involving Manipal Health Enterprises Private Limited and Manipal Education and Medical Group India Private Limited". The deals beyond a certain threshold require approval from the regulator, which keeps a tab on unfair business practices as well as promotes fair competition in the marketplace.
Fair-trade regulator CCI has approved the minority stake acquisition in Lenskart Solutions by Dove Investments, Defati Investments Holding BV and Infinity Partners. The proposed combination relates to Dove Investments, Defati Investments Holding BV and Infinity Partners' minority acquisition of certain equity shareholding of Lenskart, a notice filed with the CCI said on Monday. Lenskart Solutions Pvt Ltd (LSPL) is engaged in the business of manufacturing, sale and wholesale trading of eyewear products, while Dove Investments, Defati Investments Holding BV and Infinity Partners are private equity investors. Separately, the regulator has cleared the acquisition of securities of a newly incorporated entity of Mahindra & Mahindra Ltd by the World Bank Group arm IFC. The combination pertains to IFC proposing to subscribe to certain compulsorily convertible preference shares (CCPS) of the new unit of Mahindra & Mahindra. In March, Mahindra & Mahindra announced that the World ...
The government has extended the tenure of Atul Verma as the Director General of the Competition Commission of India (CCI) for three months. The Director General (DG) office is the investigation arm of the fair trade regulator. According to an official order, the competent authority has approved the extension of the deputation of Atul Verma as Director General of CCI for a period of three months beyond May 31. CCI is probing various anti-competitive cases, including those relating to technology companies.
It has to scale up its oversight of the digital economy and attune with new digital legislations, writes Dhanendra Kumar
Fair-trade regulator Competition Commission of India (CCI) on Thursday cleared the proposed merger of Credit Suisse Group AG with UBS Group AG. Both Credit Suisse Group AG (Credit Suisse) and UBS Group AG (UBS) are multinational investment banks and financial services companies founded and based in Switzerland. The transaction entails UBS' proposed acquisition of Credit Suisse by way of an absorption merger with UBS being the surviving legal entity, according to CCI. Post transaction, all Credit Suisse's assets, liabilities, and contracts will be transferred to UBS in their entirety. The proposed transaction has been necessitated due to Credit Suisse's financial difficulties, CCI said. Deals beyond a certain threshold require approval from the regulator, which keeps a tab on unfair business practices in the marketplace.